662 related articles for article (PubMed ID: 23596882)
21. Treatment with irbesatan may improve slit diaphragm alterations in rats with adriamycin-induced nephropathy.
Wang N; Wei RB; Li P; Li QP; Yang X; Yang Y; Huang MJ; Wang R; Yin Z; Lv Y; Chen XM
J Renin Angiotensin Aldosterone Syst; 2016; 17(2):1470320316646884. PubMed ID: 27169889
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of microRNA-130b Alleviated Podocyte Injury Induced by Puromycin Aminonucleoside
Qi CJ; Pan Y; Shen JX; Kuai QL; Zhu JX; Wang WP
Ann Clin Lab Sci; 2021 May; 51(3):393-399. PubMed ID: 34162570
[TBL] [Abstract][Full Text] [Related]
23. [Regulatory Effect of Chinese Drugs for Stasis Removing and Collaterals Dredging on the Expres- sions of podocin and CD2AP in Podocyte Slit Diaphragm of Diabetic Nephropathy Rats].
Fang J; Chen ZQ; Guo Q; Chen CY; Wang CN; Xie T; Sun R; Liu LF; Zhang X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jul; 36(7):835-841. PubMed ID: 30634212
[TBL] [Abstract][Full Text] [Related]
24. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
[TBL] [Abstract][Full Text] [Related]
25. [Effects of Qufengtongluo Recipe on podocin mRNA expression and podocyte morphology in rats with adriamycin-induced nephropathy].
Sun WS; Zhao YL; Ren YY; Ma QY
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):244-7. PubMed ID: 21354902
[TBL] [Abstract][Full Text] [Related]
26. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
[TBL] [Abstract][Full Text] [Related]
27. Quantitative analysis of markers of podocyte injury in the rat puromycin aminonucleoside nephropathy model.
Kakimoto T; Okada K; Fujitaka K; Nishio M; Kato T; Fukunari A; Utsumi H
Exp Toxicol Pathol; 2015 Feb; 67(2):171-7. PubMed ID: 25481214
[TBL] [Abstract][Full Text] [Related]
28. Dynamics of absolute amount of nephrin in a single podocyte in puromycin aminonucleoside nephrosis rats calculated by quantitative glomerular proteomics approach with selected reaction monitoring mode.
Kawakami H; Kamiie J; Yasuno K; Kobayashi R; Aihara N; Shirota K
Nephrol Dial Transplant; 2012 Apr; 27(4):1324-30. PubMed ID: 21862459
[TBL] [Abstract][Full Text] [Related]
29. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
30. Fluvastatin ameliorates podocyte injury in proteinuric rats via modulation of excessive Rho signaling.
Shibata S; Nagase M; Fujita T
J Am Soc Nephrol; 2006 Mar; 17(3):754-64. PubMed ID: 16452496
[TBL] [Abstract][Full Text] [Related]
31. Original Research: Potential of urinary nephrin as a biomarker reflecting podocyte dysfunction in various kidney disease models.
Wada Y; Abe M; Moritani H; Mitori H; Kondo M; Tanaka-Amino K; Eguchi M; Imasato A; Inoki Y; Kajiyama H; Mimura T; Tomura Y
Exp Biol Med (Maywood); 2016 Oct; 241(16):1865-76. PubMed ID: 27216597
[TBL] [Abstract][Full Text] [Related]
32. [Protection mechanisms of modified danggui buxue decoction for podocytes in adriamycin-induced nephropathy rats].
Wei MG; Zhang L; Ni L
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Aug; 32(8):1077-82. PubMed ID: 23173257
[TBL] [Abstract][Full Text] [Related]
33. Protective Effect of Salvia Przewalskii Extract on Puromycin-Induced Podocyte Injury.
Dai DS; Liu X; Yang Y; Luo XM; Tang RX; Yin ZC; Ren HQ
Am J Nephrol; 2015; 42(3):216-27. PubMed ID: 26439819
[TBL] [Abstract][Full Text] [Related]
34. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
35. Angiotensin II type 1 receptor blockade ameliorates proteinuria in puromycin aminonucleoside nephropathy by inhibiting the reduction of NEPH1 and nephrin.
Takahashi A; Fukusumi Y; Yamazaki M; Kayaba M; Kitazawa Y; Tomita M; Kawachi H
J Nephrol; 2014 Dec; 27(6):627-34. PubMed ID: 25298195
[TBL] [Abstract][Full Text] [Related]
36. Wenshen Jianpi recipe, a blended traditional Chinese medicine, ameliorates proteinuria and renal injury in a rat model of diabetic nephropathy.
Cao X; Wei R; Zhou J; Zhang X; Gong W; Jin T; Chen X
BMC Complement Altern Med; 2019 Jul; 19(1):193. PubMed ID: 31362740
[TBL] [Abstract][Full Text] [Related]
37. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats.
Okada T; Sakaguchi T; Hatamura I; Saji F; Negi S; Otani H; Muragaki Y; Kawachi H; Shigematsu T
Clin Exp Nephrol; 2009 Oct; 13(5):438-446. PubMed ID: 19452240
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
39. Newly identified cytoskeletal components are associated with dynamic changes of podocyte foot processes.
Miao J; Fan Q; Cui Q; Zhang H; Chen L; Wang S; Guan N; Guan Y; Ding J
Nephrol Dial Transplant; 2009 Nov; 24(11):3297-305. PubMed ID: 19617259
[TBL] [Abstract][Full Text] [Related]
40. MiR-124 is related to podocytic adhesive capacity damage in STZ-induced uninephrectomized diabetic rats.
Li D; Lu Z; Jia J; Zheng Z; Lin S
Kidney Blood Press Res; 2013; 37(4-5):422-31. PubMed ID: 24247359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
